Inhibitors of HMG-CoA Reductase: Current and Future Prospects
- PMID: 19929805
- DOI: 10.2174/138955709789878105
Inhibitors of HMG-CoA Reductase: Current and Future Prospects
Abstract
High levels of cholesterol are a primary risk factor in the development of cardiovascular diseases. In this review, we have summarized the structural, chemical and computational aspects of hypocholesterolemic drugs, both statins and non-statins, that target enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA) to block cholesterol biosynthesis.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
